
Remenda 11.5mg Tablet SR
Marketer
Sparsh Remedies Pvt Ltd
Salt Composition
Donepezil (11.5mg)
Overview Remenda 11.5mg Tablet SR
Alzemed SR 11.5mg tablets are indicated for managing mild to moderate Alzheimer's dementia, a debilitating condition causing progressive cognitive decline. While not a cure, this medication may offer symptomatic relief, potentially improving memory and cognitive function. Dosage and administration (ideally at bedtime with food) will be determined by your physician. Consistent use is crucial, with improvements possibly taking several weeks. Discontinuation should only occur under medical supervision. Common adverse reactions include nausea, diarrhea, sleep disturbances, vomiting, muscle spasms, tiredness, appetite reduction, headaches, upper respiratory infections, urinary leakage, and skin rashes. Maintain adequate hydration. Side effects may be more frequent initially or after dose adjustments, typically diminishing with continued use. Report persistent or severe side effects to your doctor. Prior to commencing treatment, disclose any history of cardiac issues, peptic ulcers, seizures, or respiratory conditions. Inform your physician of all other medications you are taking to avoid potential interactions. Use during pregnancy requires explicit medical approval.
Uses of Remenda 11.5mg Tablet SR
Senile dementia of the Alzheimer type
Major Benefits of Remenda 11.5mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not crush, chew, or break it. Remenda 11.5mg Extended-Release Tablets can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Remenda 11.5mg Tablet SR:
- Common cold
- Urinary incontinence
- Rash
- Nausea
- Diarrhea
- Insomnia (difficulty in sleeping)
- Weight loss
- Accidental injury
How to use Remenda 11.5mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. Remenda 11.5mg Extended-Release Tablets can be administered with or without food, although consistent timing is recommended.
How Remenda 11.5mg Tablet SR works:
Cognitive decline characteristic of Alzheimer's arises from impaired neuronal communication. Remenda 11.5mg SR tablets function as a cholinesterase inhibitor, elevating acetylcholine—a neurotransmitter crucial for nerve signal propagation—thus enhancing cognitive function and memory.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Remenda 11.5mg Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Remenda 11.5mg Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Remenda 11.5mg SR tablets while breastfeeding is likely inadvisable. Insufficient human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving is inadvisable if you experience drowsiness, dizziness, blurred vision, or reduced alertness after taking Remenda 11.5mg SR Tablets. These side effects are possible.
KidneySAFE IF PRESCRIBED
Use of Remenda 11.5mg Tablet SR in individuals with kidney impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Remenda 11.5mg sustained-release tablets. Dosage modification of Remenda 11.5mg sustained-release tablets may be necessary. Physician consultation is recommended.
What if you forget to take Remenda 11.5mg Tablet SR :
Omit any missed dose of Remenda 11.5mg Extended-Release Tablet and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Remenda 11.5mg Tablet SR
| Label | Value |
|---|---|
| Chemical Category | Carbamate-based compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Behavioral Class | Treating Alzheimer's with Cholinesterase Inhibitors |
